Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT | Market Cap | 66.20B +29.3% |
| Revenue (ttm) | 53.93B +12.4% |
| Net Income | 8.65B +28.9% |
| EPS | 19.39 +28.9% |
| Shares Out | 446.11M |
| PE Ratio | 7.65 |
| Forward PE | 7.64 |
| Dividend | 4.75 (3.20%) |
| Ex-Dividend Date | Aug 3, 2026 |
| Volume | 349,479 |
| Open | 149.20 |
| Previous Close | 149.40 |
| Day's Range | 148.10 - 150.00 |
| 52-Week Range | 99.50 - 158.50 |
| Beta | 0.24 |
| Analysts | Strong Buy |
| Price Target | 198.55 (+33.79%) |
| Est. Earnings | Nov 3, 2026 |
About DSE:BXPHARMA
Beximco Pharmaceuticals PLC. manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh and internationally. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufactu... [Read more]
Financial Performance
In fiscal year 2025, DSE:BXPHARMA's revenue was 49.12 billion, an increase of 10.65% compared to the previous year's 44.39 billion. Earnings were 6.94 billion, an increase of 19.06%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for BXPHARMA stock is "Strong Buy." The 12-month stock price target is ৳198.55, which is an increase of 33.79% from the latest price.
News
Small Cap Stocks: Indus Gas, VAST Resources, Beximco
Indus Gas, VAST Resources, STM Group, Beximco Pharmaceuticals, Gunsynd are the biggest Small Cap stock movers